1 million IU/ml | 3 million IU/ml | p Value | |
No of eyes (patients) | 21 (19) | 12 (9) | |
Median age (years (range)) | 60 (23 to 82) | 72 (36 to 82) | 0.44 |
Gender (percentage male) (n/N) | 26% (5/19) | 56% (5/9) | 0.13 |
Race | |||
Percentage white (n/N) | 42% (8/19) | 67% (6/9) | 0.43 |
Percentage Hispanic (n/N) | 53% (10/19) | 33% (3/9) | |
Involved eye (percentage right eye) (n/N) | 43% (9/21) | 42% (5/12) | 0.95 |
Recurrent ocular surface squamous neoplasia (n/N) | 33% (7/21) | 33% (4/12) | 1.00 |
Previous interferon use (topical or injections) | 10% (2/21) | 17% (2/12) | 0.55 |
Median area of CIN (mm2 (range)) | 19 (2 to 88) | 23.8 (2 to 120) | 0.99 |
Biopsy proven CIN* | 86% (18/21) | 67% (8/12) | 0.20 |
↵* Biopsy of either previous or current lesion.